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We used transgenic mice carrying the laIreporter gene to study the mutagenesis potential of
asbestos crocidolite. The animals were exposed by nose-ondy inhalation to an aerosol containg
5.75 mg/m3 crocidolite dust for 6 hr/day and 5 consecutive days. After 1, 4, and 12 weeks, we
examined fourend points: thecytologyofbronchoalveolar lavage, the lungload ofcrocidolite, the
hydrophobic DNAadducts, and the mutations in the lacIreporter gene. Twelve weeks after expo-
sure, nearly 10% ofthe inhaled fibers remained in the lung (227 ± 103 ng/mg lung). There was
evidence ofa typical inflammatory response consisting ofmultinudeate macrophages at weeks 4
and 12, whereas immediately after the exposure, we observed numerous polymorphonudear neu-
trophils. The mutantfrequencysignificatively increased during the fourth weekafter the exposure:
13.5 x 10-5 in the exposed group versus 6.9 x 10-5 in the control group. The induction factor,
definedbythe ratio ofchecked mutants ofexposed mice to checke mutants ofcontrol mice, was
1.96. Themutationspectrum ofcontrol lungDNAand exposedlungDNAwassimilar, suggesting
thepossibleinvolvement ofa DNArepairdecrease incrocidolite-treated animals. We usedthe32p-
posdabeling method and did not detect any increase ofeither 5 mC or bulky adduct in treated
mice. This is the first study that demonstrates asbestos mutagenicity in vivo after a nose-only
inhalation. Key words adduct, asbestos, crocidolite, lung DNA, keIgene, macrophage, mutation,
transgenic. EnvironHealhPerspect108:341-346 (2000). [Online 23 February2000]
http://ehpnetl.niehs.nih.gov/docs/2000/108p341-346rihnJabstract.htmI
Although the use ofasbestos fibers has been
banned in most industrialized countries,
they are still a major environmental, occupa-
tional, and personal health concern. Asbestos
fibers are considered tumorigenic and
mutagenic for humans according to the U.S.
Registry of Toxic Effects of Chemical
Substances (1).
Physical dimension, biopersistence, sur-
face reactivity, and fiber overload are all
involved in the pathogenesis of asbestosis,
bronchogenic carcinoma, and mesothelioma
[reviewed by Kane (2)]. At the molecular
level, oxidative stress and cytokine release by
alveolar macrophages (AMs) and neu-
trophils are invoked in the pathogenesis of
these illnesses (2).
Asbestos is thought to be a complete car-
cinogen (3), which means that it has the
capability to initiate and promote tumors.
Because asbestos fibers are not directly elec-
trophilic, it has been proposed that asbestos
is not a mutagenic compound per se (4). In
fact, past in vitro studies have shown no
mutagenic or weak mutagenic activity of
asbestos samples [reviewed by Jaurand (5)].
Using the Salmonella typhimurium TA 102
oxidative stress sensitive strain, Faux et al.
(6) showed mutagenicity induced by croci-
dolite, but not by chrysotile (chrysotile is the
most-used asbestos worldwide). However,
the mammalian cell paradigm found
mutagenicity for both crocidolite and
chrysotile at the S, locus (7) and for 50
pg/mL chrysotile at the HLA-A locus.
Nevertheless, no mutagenicity was manifest-
ed at the HPRTlocus (7-9) with crocidolite
fibers. Furthermore, crocidolite induced a
loss of heterozygosity in vitro at the HLA-A
locus (10), as did chrysotile in Big Blue
transgenic Rat 2?. cells (Stratagene, La Jolla,
CA) at the X locus (11).
Although many experimenits have been
performed in vitro to demonstrate the muta-
genicity of asbestos (clastogenic effects and
mitotic abnormalities), there is a lack of in
vivostudies to assert this important property.
Thus we investigated more extensively the in
vivo mutagenesis potential, ifany, ofasbestos
fibers. To our knowledge, no mutagenesis
studies have been conducted on whole ani-
mals. We used a transgenic mouse system
carrying the lacI reporter gene and investi-
gated the effect of crocidolite fibers in a
short-term assay. The animals were exposed
by nose-only inhalation for 5 days, then four
end points were analyzed: the inflammatory
response of the lung, the lung burden of
fibers, the DNA adduct formation, and the
mutation rate as well as the position and the
nature of the mutation on the lacI reporter
gene induced by crocidolite fibers.
Materials and Methods
Mice. We obtained transgenic male Lacl
mice C57/B16 (lambda LIZ, BigBlue) from
Stratagene. The mice were randomized and
numbered by tattoo. The animals were
housed in polycarbonate cages (1/cage) cov-
ered with spun-bonded polyester cage filters.
The room temperature was 21 ± 1°C, and
the pressure was 5 mm H20 above the
atmospheric pressure. The humidity ranged
from 40 to 60% and a fluorescent light was
on for 12 hr/day. The animals were fed with
pellet food and water ad libitum. Two-
month-old animals were exposed to the cro-
cidolite aerosol; control animals were housed
in nose-only exposure tubes without croci-
dolite during the experiment (6 hr/day for 5
days). We terminated the experiment 1, 4, or
12 weeks after the beginning ofthe exposure,
depending on the animal group.
Exposure techniques. The crocidolite
sample used in this study came from a batch
(gift of R.E.G. Rendall, National Center for
Occupational Health, Johannesburg, South
Africa) that replaced the original Union
Internationale Contre le Cancer (Geneva,
Switzerland) sample when it ran out. The
fiber size distribution of the gift batch is
extensively described in a previous study (12).
The elementary analysis of this crocidolite
sample was checked by emission spectroscopy
(ICAP 61E; Thermo Jarrell Ash, Franklin,
MA). The result of the analysis, expressed as
the mean ofthree determinations, in percent,
was Mg, 1.49; Si, 22.8; Fe, 30.0; Mn, 0.097;
Al, 0.05; Cr, < 0.002; and Ni, 0.017.
The fiber aerosol generator was previous-
ly described by Rihn et al. (12). In brief, the
fibers were packed into a cylinder and pushed
with a Teflon-coated piston on a steel brush.
Clean air was provided by a six-bar compres-
sor that delivered a 100-L/min air stream by
an inverted cyclone device. The tangential
position ofthe air inlet pipe gave the air flow
a helicoidal movement from the top to the
bottom of the cell to ensure the aerosol
homogeneity. The aerosol concentrations
were monitored online by photometry.
We used the chamber as previously
described by Rihn et al. (12). Briefly, the
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control process included measurements of
the air flow, the depression, the temperature,
and the humidity. We transferred all output
signals to a computer, which processed sen-
sor information, calculated regulation loops,
and dispatched analogical tensions to the
regulation valves. A second computer was
connected to the first and was used to moni-
tor the inhalation chamber conditions (air
flow and relative humidity), the aerosol con-
centration, and the adjustments of the
aerosol generator parameters. The tempera-
ture of the atmosphere was maintained
between 20 and 22°C, the humidity
between 40 and 60%, and the air volume
exchange (100 L) was 60 times/hr. To avoid
contamination of ambient air by inhalation
of chamber pollutants, pressures inside the
inhalation chamber and the glove box sur-
rounding the chamber were maintained
below the room pressure at 5 and 2.5 mm
H20, respectively.
Animals were housed in transparent
restraining tubes inserted in the inhalation
chamber, a stainless concentric cylinder with
a 48-tube capacity. The mice were continu-
ously exposed nose only to the crocidolite
aerosol (subjects) or to the ambient air (con-
trol mice). Small holes in each of the
restraining tubes prevented hyperthermal
effects. This flow-past design allowed each
animal to breathe fresh crocidolite aerosol of
well regulated particle concentration and size
at all times; reinhalation of exhaled test
atmosphere was minimized. The fraction of
exhaled air in the chamber was < 1/1,000 on
the basis of regular mouse breathing (25
mL/min/mouse) (13).
Atmosphere control. We determined the
concentration of airborne dust by sampling
on GF/C filters (Whatman International
Ltd., Maidstone, UK) for 5-6 hr at a flow
rate of 2 L/min. The sampling head was an
open-faced Millipore cassette (Millipore,
Bedford, MA). The weight of the filters
before and after sampling was corrected
according to the weight variations of three
unexposed filters.
To determine the fiber number, we chose
a short sampling period (5-10 sec) to avoid
fiber amounts that were too high fiber and to
avoid filter overload. We used 0.8-pm mixed
ester cellulose membranes to sample the
fibers, which were counted by phase-contrast
microscopy (12). We assessed the fiber size
distribution ofeither the aerosol or the bulk
crocidolite sample by transmission electron
microscopy (IOOCX; JEOL Ltd., Tokyo,
Japan). For this measurement, the fibers were
deposited on a Nucleopore (Millipore) filter
covered with a thin layer ofcarbon.
To check the absence of contaminating
metals produced by the generator, we also
sampled dust on Whatman QM-Afilters and
analyzed by emission spectroscopy (ICAP
61E; ThermoJarrellAsh, Franklin, MA).
Cytologic, histologic, and ultrastructural
examinations. At the end ofeach time-point,
we measured bronchoalveolar liquids by
washing the lung 2 times with 500 pL phos-
phate buffered saline solution (pH 7.4). We
determined the cell number after Trypan
Blue (0.04% w/v) staining, and the nucleated
cells were recorded in triplicate using a
Thoma-Weiss counting cell (PolyLabs,
Strasbourg, France). In addition, a portion of
the bronchoalveolar liquid (100 pL) was
spun for 5 min at 29g(Cytospin 2; Shandon,
Pittsburgh, PA). The May Griinwald Giemsa
staining was then performed and AMs, poly-
morphonucleated cells (PMC), and the lym-
phocytes (L) were counted. Our results are
the mean ofthree independent measures.
For histologic observations, we fixed
lung specimens from control and treated
animals in Bouin's solution or in 4% (v/v)
aqueous formalin solution, then embedded
in paraffin, sectioned, stained with hema-
toxylin/eosin, and evaluated by adapting the
Wagner scale as described previously (12)
with an Ortoplan microscope (Leitz,
Wetzlar, Germany).
To evaluate the fiber burden in the
lungs, we cleaned the frozen left lobe offour
control and four treated animals in acetone
to remove the fat, dried them to constant
weight, and reduced them to ashes in a low-
temperature oven (150°C) for 2 hr. The
ashes were gently homogenized in ultrapure
water by handshaking, then filtered over a
carbon-covered Nucleopore membrane (25
mm diameter, 0.4 pm pore size). We did not
choose ultrasonic treatment because we pre-
viously demonstrated that this treatment can
change the fiber size distribution (12). The
retained particles were covered with a second
layer of carbon. Under this prepared filter,
five electron microscopy grids were deposit-
ed onto the filtering apparatus. Ten milli-
liters ofchloroform was filtered through the
grids to dissolve the Nucleopore filters and
retain the fibers, if any, on the grids. We
observed the fibers with the transmission
electron microscope (Jeol 100CX) at
33,OOOx magnification. This technique
allowed us to determine the quantity of
fibers and the volume and the mass that
could be calculated with the knowledge of
the density (d = 3.35 g/cm3). Finally, we
determined the ratio ofthe fiber mass to the
lung weight (expressed in nanograms per
milligram lung).
Lung DNA extraction, in vitro packag-
ing, and mutation analysis. We prepared
high-molecular-weight lung DNA from a
small piece of lung (100 mg) according to
the protocol developed by Stratagene (14).
After homogenization (six strokes in a
dounce) using Rnace-it buffer (Stratagene),
the DNA samples were phenol/chloroform
extracted, then we carefully ethanol
precipitated the samples and resuspended
them in 500 pL TE (Tris-HCl, 10 mmol,
EDTA 1 mmol, pH = 8.0). Before packag-
ing, the DNA was electrophoresed in 1.5%
agarose gel to check the size and control the
absence ofa smear below 50 kB. We recov-
ered the lambda-shuttle vector in viable
phage by incubating the extracted DNA
(approximately 50 pg) with the terminase
and the phage proteins contained in the
Transpack (Stratagene) as described by the
manufacturer. We matched control and
exposed animals for each packaging reaction.
The average of plaques per packaging reac-
tion was 38,000, and varied from 19,000 to
69,000. There was no statistical difference
for transformation efficiency between con-
trol and exposed animals. The in vitro pack-
aged phages were adsorbed on E. coli SCS-8
cells and screened for blue mutant plaques
on 625 cm2 NYZ agar plates containing 1.5
mg X-gal/ml top agar. The plaque density
varied from 8,000 to 10,000 per assay tray.
We applied internal color sensitivity control
(CMO, CM1, CM2, and CM3; Stratagene)
for each plating. Incubation lasted between
16 and 20 hr and the blue mutants were
screened usinga red filter.
We confirmed the phenotype of each
mutant plaque by phage replating at low
density in the presence ofX-gal. The phage
was further isolated by coring the plaque and
resuspending the phage in the buffer
described in Stratagene's protocol (14). We
extracted DNA and amplified it with the
appropriate primers ofthe lad gene for fur-
ther sequencing (forward direction 1781:
GACACCATCGAATGGTGAAAAC;
reverse direction 1780: CCGCTCA-
CAATTCCACACAACAT). The lad gene
of60 phages from both control and exposed
mice was entirely sequenced using the six
primer sets recommended in the BigBlue
protocol (14) to determine the distribution
of the mutations. We determined the
sequences using theAbi prism dye terminator
cycle sequencing ready reaction kit (Perkin
Elmer Biosystems, Foster City, CA) on a
373Asequencer (Perkin Elmer Biosystems).
Screeningfor bulky adducts and deter-
mination ofm5dClevelin DNA. We detect-
ed hydrophobic DNA adducts using the
[32P]-postlabeling method, which had not
previously been used, to check the presence
ofDNA adducts in asbestos studies. Briefly,
the DNA was digested into 3'-phosphonu-
cleosides by micrococcal nuclease and spleen
phosphodiesterase. Adducts were privileged
versus normal nucleotides by nuclease P1
enrichment. We postlabeled the adducts
using [y 32P]-adenosine triphosphate (ATP)
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and T4 polynucleotide kinase, as described
previously (15). The adducts were chro-
matographed on PEI-cellulose thin-layer
plates using four solvents: NaH2PO4 2.3 M,
pH = 5.7; urea 6.25 M, lithium formate 3.25
M, pH = 3.5; urea 7.5 M, lithium formate
4.25 M, pH= 3.5; andNaH2PO4 1.7 M.
For the m5dC determination, we
hydrolyzed the DNA into 3'-phosphonucle-
osides that were labeled directly with y[32p]-
ATP. The resulting [32P]-5',3'-diphospho-
nucleosides were further hydrolyzed into
[32P]-5'-monophosphate nucleosides by
nuclease Pi. The labeled mononucleotides
were separated on cellulose plates (F1440;
Schleicher and Schiill, Dassel, Germany) and
revealed using the solvents as previously men-
tioned (15). We used radioautography to
detect the labeled nucleotides and we evaluat-
ed the radioactivity using a Bio-Imager
Bas2000 analyzer (Fuji, Tokyo,Japan).
Results
Measurement ofthefiber concentration in
the chamberandin the lungofthe mice. We
measured the dust concentrations in the
chamber by sampling onto glass filters 6
hr/day, as described in "Materials and
Methods." The dust concentration mean
was 5.75 ± 0.87 mg/m3. The average fiber
density was 1,875 ± 1,216 fibers/cm3 (n =
24) when we considered only the fibers > 5
,um in length and < 3 ,um in diameter. The
fiber size distribution was similar to that ofa
previous study (12). The proportion offiber
that met Stanton's criteria (16) did not vary
over the experiment time and remained
< 3% ofthe overall fibers; thus the crocido-
lite aerosol used in our study was mainly
composed ofshort fibers (Table 1). The ele-
mentary fiber analysis either in the inhala-
tion chamber or in the mice lungs did not
show any difference as compared to the ini-
tial crocidolite sample (data not shown).
We checked the lung fiber content in
four control and four exposed mice 1 week
and 12 weeks after the intoxication. No
fibers were detected in control mice after
either 1 or 12 weeks. Indeed, the measured
mass offiber was < 1 ng/mg lung (Table 2).
In contrast, exposed animals had an average
of693 ± 496 ng fibers/mg lung correspond-
ing to 1.63 X 106 (± 1.19 x 106) fibers/mg
lung 1 week after the intoxication. Twelve
weeks later, the lung content was still 227 ±
103 ng/mg corresponding to 0.62 x 106
(± 0.21 x 106) fibers/mg lung. When con-
sidering normal breathing of25 mL/min air,
on average, 17.1 and 6.6% of the total
inhaled fibers (estimated approximately to
84.4 x 106) lasted 1 and 12 weeks, respec-
tively, in the mice lung after the intoxica-
tion. The average ofthe length-on-diameter
ratio was 19.15 and 19.88 at 1 and 12 weeks
after the exposure, respectively (p > 0.05).
Moreover, the fiber size distribution
remained unchanged in the lung after 12
weeks and was similar to the fiber size distri-
bution ofthe aerosol sample (Table 1).
Cellular responses ofthe bronchoalveolar
liquids. Table 3 shows the cellular response
ofthe 1-, 4-, and 12-week series. One week
Table 1. Size distribution ofthe fibers inthe exposed animals and ofthe crocidolite aerosol.
Sample L<5 pm 5 pm < L<20 pm L>20 pm Stanton's fibera L/D ratio
Treated, 1 weekb 86.3 ± 5.0 13.6 ±4.9 0.2 ±0.3 2.9± 1.7 19.15 ±2.39
Treated, 12weeksb 86.6+2.0 13.1 ±2.1 0.3± 0.2 2.1 ±0.6 19.88 ± 1.44
Aerosolc 91.1 8.4 0.4 2.3
Abbreviations: D, diameter; L, length.
'L> 8 pm, D < 0.25 pm. bn = 4; Rihn et al. (12) shows the precise aerosol description. cTypical fiber size distribution of an
aerosol sample.
Table 2. Fiber load in lung.
Mice groupa Lung weight(mgl Fiber number Fiber mass(ng/mg) Wagner scale
Control, 1 week 8.28 ± 0.55 Not detectable < 1
Treated, 1 week 8.86 ± 1.16 1.63 x 106(l1.19 X 106) 693 ± 496
Control, 12 weeks 9.38 ± 0.86 Not detectable < 1 1.0 ± 0.0
Treated, 12 weeks 8.95 ± 0.09 0.62 x 106(± 0.21 x 106) 227 ± 103 1.7 ± 0.5
an = 4for each group.
after the intoxication, the number of viable
cells elevated dramatically because ofa huge
increase of PMCs and lymphocytes.
However, the number of AMs with two
nuclei was approximately 13 times higher in
the treated group as compared to the control
group. In addition, syncitia composed of
three or more macrophages appeared in the
exposed group.
Four weeks after the intoxication, only
AMs with two or more nuclei were increased.
Twelve weeks after the intoxication, the
number ofAMs was still increased and the
AM population was responsible for the
increase in total viable cells. The averages of
Wagner scores were 1.0 and 1.7 for control
and exposed mice, respectively, indicating an
alveolar inflammatory response but no
fibrosis in the lung (Table 2).
Mutantfrequency and mutation spec-
trum determinations. More than one million
genetically independent events were analyzed
for each mouse set. We used approximately
55-60 transpack reactions for each time
point. The mutant frequency significantly
increased 4 weeks after the intoxication: 13.5
x 10-5 ± 1.7 x 10-5 in the exposed group ver-
sus 6.9 x 10-5 ± 1.1 x 10-5 in the control
group (Table 4). The induction factor,
defined by the ratio of checked mutants to
exposed mice versus checked mutants of
control mice, was 1.96 (p < 0.05). In con-
trast, 1 and 12 weeks after the intoxication,
the mutant frequencies ofboth mice groups
were not significantly different.
We determined the mutation spectrum 4
weeks after the exposure for 60 mutant
plaques that were sequenced in both groups.
Considering the 60 lad genes from mutant
plaques sequenced for each group, there were
no significant differences between control
andexposed mice, as mentioned in Table 5.
We located the mutation positions for
both groups (Figure 1). No difference
appeared in the location between exposed
and control mice (65 and 62 mutations
determined, respectively). Similarly, there
were no differences in either the 1-week or
the 12-week groups (data not shown).
Bulky adducts and methylation status.
The formation of bulky DNA adducts was
ruled out by the [32p] postlabeling method
(15). As shown in Figure 2A and B, there
Table 3. Cellular response ofthe bronchoalveolar liquid after 1,4, and 12 weeks after exposure.
Week Group AM1 AM2 AM3 PMC Lymphocytes Viable cells
1 Control 49,000 ± 19,800 230 ± 190 0 ± 0 490 ± 550 230 ± 270 50,000 ± 20,400
1 Treated 41,100 + 20,000 3,100 ± 2,100* 800 ± 700* 380,000+390,000* 4,400 ± 3,000* 437,000 ± 390,000*
4 Control 43,700 ± 24,100 320 ± 190 0 ± 0 690 ± 1,000 270 ± 530 45,000 ± 24,300
4 Treated 32,800 ± 10,900 1,900 ± 600* 340 ± 160* 260 ± 320 220 ± 240 34,400 ± 11,900
12 Control 20,900 ± 11,900 120 ± 100 0± 0 50 ± 40 0± 0 21,500± 11,400
12 Treated 44,900 ± 13,400 900 ± 280* 130 + 100* 120 ± 70 50 ± 60 46,100 ± 13,700*
AM1, AM2, and AM3 are alveolar macrophage with one, two, and three or more nuclei, respectively.
*Significant at p < 0.05 calculated using the Student's t-test (n = 9; three independent measures per animal).
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was no difference in the DNA adduct pro-
files: both exhibited the same adducts, i.e., I-
compounds generated by the endogenous
metabolism. A slight decrease in the total
amount ofthese I-compounds was detected:
160 versus 60 per 109 nucleotides for control
and treated mice, respectively. In addition,
the m5dC/dC ratios measured in lung DNA
were 3.0 ± 0.7 (n = 16) in control mice ver-
sus 3.5 ± 0.4 (n = 16) for the exposed mice.
There was no statistical difference in the
m5dC/dC ratio (p > 0.01) because it was
assessed by radioactivity counting of m5dC
and dC spots on thin-layer chromatography
byphosphorimaging.
Discussion
The cumulated dose ofasbestos administrat-
ed in our study by inhalation was low (5.75
mg/m3 for 5 days) as compared to previous
long-term assays on rodents (10-50 mg/m3
for200-500 days) (17). Taking into account
the average ventilation volume of a mouse,
the total inhaled dose of inhaled dust was
0.26 mg/mouse, approximately correspond-
ing to < 0.5% ofthe average inhaled dose in
classical long-term assays. However, it is
remarkable that 6.6% of the inhaled dose
was still in the lung 12 weeks after the end of
the intoxication. Contrary to other studies,
there was no overload effect in our study
because < 10% (_ 9 x 106) of the total
inhaled fibers was present in the lung 4
weeks after the inhalation when the muta-
genic effect was significant. The Wagner
scores of both groups were similar, indicat-
ing that the crocidolite dose was far below
the maximum tolerated dose and thus avoid-
ing overload effects (18). Moreover, the
length/diameter ratio and the size distribu-
tion ofthe fibers deposited in the lung were
similar 1 and 12 weeks after a 5-day expo-
sure (Table 1). This similarity shows that in
this period of time all fibers, whatever the
size, had the same probability to be cleared,
which contrasts with long-term assays in
which short fibers are removed from the
lung more rapidly than long fibers (19). It
would be interesting to study the mutagenic
effect ofan asbestos batch composed mainly
of long fibers (> 20 pm). Coin et al. (19)
showed that chrysotile long fibers, which are
more carcinogenic (16), remained for at least
6 months in the lung after a short treatment
comparable to the present study.
Asbestos fibers induce chromosomal
changes in human cultured cell lines.
Crocidolite and chrysotile (2 mg/cm2)
induced anaphase aberrations and abnormal
mitoses in human immortalized mesothelial
cell lines (20). In human lymphocytes, chro-
mosome and chromatid breaks have also
been reported, as well as polyploidy, provid-
ed that the dose was higher than 2 x 105
fibers/cm2 (approximately 5 fibers/cell) (5).
This dose is higher as compared to the dose
used in vivo in the present study.
Considering a total lung area of700 cm2 for
a 3-month-old mouse (13) and a total num-
ber ofalveolar type I and II cells of26 x 106,
the number offibers per cell can be estimat-
ed 4 weeks after the intoxication as 0.35
fibers/cell. This value is not surprising
because generally the doses needed to show
in vitro effects are higher than those needed
to show in vivo effects. After our study, we
can conclude that mutations occur using a
dose below the dose necessary for chromo-
some abnormalities. Asbestos fibers also
induce binucleation, which is a consequence
ofmitotic abnormalities in pleural mesothe-
lial cells and macrophages. In the current
study, binucleated and multinucleated AMs,
known as biomarkers of fiber burden,
increase significantly after 4 and 12 weeks:
these results were similar to those published
previously (12).
The first in vitro gene mutation assay
(i.e., the Salmonella typhimurium assay) was
not relevant for testing the mutagenicity of
crocidolite. An improvement of the Ames
test using the TA102 strain showed a muta-
genic potential of 50 pg/cm2 crocidolite
because ofits sensitivity to oxidative damage
(6). The hypoxanthine guanine phosphori-
bosyl transferase locus (HPRI) has been
investigated in rat liver, Chinese ovary, or
human-hamster fibroblasts, but a mutagenic
effect of crocidolite could not be demon-
strated for any of the the cell systems used
[reviewed by Jaurand (4)]. Therefore, it
appears that the BigBlue transgenic system
allows a more realistic picture of the geno-
toxic effects of an asbestos exposure in vivo.
In such studies, a nonessential and silent
gene, the so-called reporter gene, was used
for mutation studies. With this latter system,
each point mutation is detected in contrast
to assays based on the HPRT locus, which
are generally phenotypic end points.
Recently, however, Park and Aust (21)
improved the HPRTlocus assay by using
hprt- andgpt+ G12 cells where the transgenic
gptgene is located on an autosomal chromo-
some, making this assay useful for asbestos
mutagenicity testing. The improved assay
showed a 2-fold increase of the mutant fre-
quencywith a 6-pg/mLdose ofcrocidolite.
Recent studies using transgenic rodents
exposed to benzo[a]pyrene compared the
mutant frequencies in both hprt and lad
genes. The lad genes were 40 times more
sensitive to a 150-mg/kg benzo[a]pyrene
treatment in splenic T cells (22). Such dis-
parity could be due to the phenotypic expres-
sion ofthe concerned gene. In fact, lad does
not require in vivo expression, whereas the
resistant 6-thioguanine phenotype (hprf) is
required in T cells. Other factors could be
the different rate of benzo[a]pyrene adduct
formation and repair processes in both
genes. The lad is a silent gene in the mouse;
it is possible that the repair, before transla-
tion, is involved in a more efficient manner
in the hprtgene. Therefore, it appears that a
nonexpressed ladtransgene is more appropri-
ate to studythe genotoxicityofcompounds or
particles such as asbestos than other end
points based on the loss ofheterozygosity of
the HLAlocus or hprfphenotyping.
In our study, we sequenced the lad gene
using the six primer sets in > 60 mutant
colonies isolated from exposed and control
mice that represented > 576,000 sequenced
bases. We assessed the nature and the position
ofeach mutation. The mutation frequency of
control mice in our study varied from 6.9 x
10-5 to 8.7 x 10-5. These values are slightly
higher than the spontaneous mutant frequen-
cy determined in lung by de Boer et al. (23).
This variation could be due to differences in
the experimental conditions (e.g., the age of
Table 4. Results of the in vivo mutagenesis assay
using lung DNA.
Week, group, Plaques Mutant
mouse ID (n) frequency
One week
Control
1 413,130 0.000073
2 367,230 0.000114
3 575,510 0.000075
Mean ± SD 0.000087± 0.000023
Total plaques 1,355,870
Exposed
4 333,700 0.000093
5 366,620 0.000074
6 423,310 0.000076
Mean ± SD 0.000081 +0.000010
Total plaques 1,123,630
Fourweeks
Control
7 350,130 0.000080
8 359,040 0.000058
9 350,410 0.000068
Mean ± SD 0.000069*± 0.000011
Total plaques 1,059,580
Exposed
10 409,920 0.000154
11 370,850 0.000124
12 221,880 0.000126
Mean ± SD 0.000135*± 0.000017
Total plaques 1,002,650
Twelve weeks
Control
13 336,380 0.000134
14 353,870 0.000065
15 364,650 0.000058
Mean ± SD 0.000086± 0.000042
Total plaques 1,054,900
Exposed
16 351,230 0.000068
17 337,200 0.000184
18 343,500 0.000079
Mean ± SD 0.000110 ± 0.000064
Total plaques 1,031,910
*Significant(p< 0.01,t-test).
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the mouse, the plating density, or DNA
extraction). Table 5 and Figure 1 show that
the mutation spectrum is similar in both
groups, suggesting that the increased num-
ber ofmutations could be due to an oxida-
tive stress directed randomly against all
nucleotides rather than to a direct and spe-
cific mutagenic effect offibers, as is seen for
initiating compounds such as o-anisidine
and benzo[a]pyrene. The reactive oxygen
species (ROS) could be produced by the
macrophages and neutrophils burst, as
assumed by Hei et al. (24), or by extracellu-
lar compounds due to fiber surface reactivity
(25-27). ROS induce mostly deletions and
insertions (28); Lezon-Geyda et al. (11)
used an in vitro assay based on the same
principle (10). Moreover, the BigBlue test is
unable to detect large insertions and
deletions ofDNA because these phenomena
change the size of the X phage genome,
which cannot be packaged. However an in
vitro adaptation of the BigBlue system,
using cultured Rat 2 X fibroblasts, allowed
Lezon-Geyda et al. (11) to demonstrate a
2.5-fold increase of the mitotic recombina-
tion after a 6-gg/mL treatment of crocido-
lite, thus making this test useful for
insertion/deletion studies. Although the pos-
sibility ofmutations through large insertions
and deletions cannot be excluded in our test
conditions, and because we found a clear
increase of the mutant frequency, the exact
mutation frequency due to asbestos is
probably underestimated.
Table 5. Mutation spectrum.
Mutation type Control Treated
Transition
G:C XA:T 1 (18.3) 15(25.4)
A:T= G:C 4(6.6) 2 (3.4)
Transversion
A:T =>T:A 0(0) 1 (1.7)
A:T=C:G 2(3.3) 1 (1.7)
G:C T:A 8(13.3) 7(11.9)
G:C=C:G 1 (1.7) 2(3.4)
Insertion/deletion 30(50.0) 31 (52.5)
Complex 4(6.7) 1(1.7)
Total 60 60
Mutations on CpG sites 10(16.7) 17 (28.3)
The percentage is indicated in parentheses.
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Figure 1. Mutation position on the lacl gene.
Sixty-five control and 62 treated mutant plaques
were sequenced for both mice groups 4 weeks
after exposure. For insertion and deletion, only
the firstmodified base was marked.
It is also possible that asbestos impaired
the repair potential ofthe cells, as shown by
Okayasu et al. (29). An 8-pg/mL dose of
chrysotile decreased the cell survival and the
double strand repair efficiency of double
strand repair deficiency cells (xrs-5) as com-
pared to wild-type cells (Chinese hamster
ovary cell). The repair potential ofDNA was
not verified in the present study. Regardless
ofthe mechanism involved, one can hypoth-
esize that the mutant frequency must have
increased because of oxidative stress above
the repair ability oflung DNA.
McGavran et al. (30) showed that a
short-term chrysotile exposure (4 mg/m3)
induced cellular proliferation, as assessed by
in vivo [3H]-thymidine incorporation, in
epithelial as well as interstitial lung cells.
Adamson (31) reported similar findings in
lung cells after a single intratracheal adminis-
tration of0.1 mg crocidolite. Adamson (31)
showed a proliferation of mesothelial and
fibroblast cells that peaked at 2% labeled
nuclei and lasted for 3 weeks. Such an effect
was also reported on mesothelial cells in
Fischer 344 rats exposed to 8 mg/m3 croci-
dolite for 20 days (32). Using our experi-
mental design (a moderate dose of0.26 mg
crocidolite for 5 days and a physiologic route
for the toxicant), one can hypothesize that a
proliferation occurred in lung. Mitogenic
factors released in the milieu (33,34) by the
oxidative stress may fix the mutations shown
4 weeks after the crocidolite exposure. The
decrease of the mutant frequency in the
exposed mice ofthe 12-week series could be
explained by epithelial regeneration and
restored DNA repair after the acute exposure
period. The induced cell death could also
explain the normalization ofthe mutant fre-
quency seen after 12 weeks. Indeed, as
demonstrated by Broaddus et al. (25), a fiber
dose of 5 pg/mL induced apoptosis on
mesothelial cells in a ROS-induction man-
ner because the apoptosis process was inhib-
ited by extracellular catalase and superoxide
dismutase enzymes.
Adachi et al. (35) reported an increase of
dOH8dG after an in vitro coincubation of
deionized crocidolite and DNA. Furthermore,
Takeuchi and Morimoto (36) showed an
increase ofthis modified nucleotide in HL60
human cells treated with crocidolite andphor-
bolmyristate acetate, astrongmitogenicfactor
as well as an inducer ofROS. However, they
measured the total cell DNA, which could
have been contaminated by mitochondrial
DNA. dOH8dG is an early indicator of
mitochondrial DNA injury (37). Future
studies should determine the dOH8dG level
in both nuclear and mitochondrial DNA. In
our study, the mutation spectra of both
groups of animals showed no statistical dif-
ference in the involvement of CpG sites
(Table 5). Because mitochondrial DNA rep-
resents < 1% oftotal DNA, our results were
not able to reveal a specific increase of this
kind ofmutation on dG nucleosides therein.
We did not find an excess ofadducts in
the present study in exposed mice. This is
not surprising because the [32P]-postlabeling
method detects only the bulky adducts.
Inversely, the number of bulky adducts per
genome seems more important in the control
mice as compared to exposed animals: a simi-
larfinding was already noted by Randerath et
al. (38), who found a gradual depletion ofI-
compounds during carcinogenesis in rodents.
Howden and Faux (39) reported the pres-
ence ofDNA adducts byusing a fluorescence
technique and demonstrated the role oflipid
peroxidation products as malondialdehyde.
This in vitro paradigm, however, was far
from thephysiological conditions. Moreover,
A B
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Figure 2.Thin-layer chromatographies oflung DNA adducts of a (A) control and (B) exposed mouse.
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the [32P]-postlabeling method is more sensi-
tive and detected only I-compounds using
an in vivo paradigm in both exposed and
control animals.
Conclusions
We demonstrated a significant increase of
the mutant frequency (approximately twice
that ofthe control) oflung DNA for the first
time in crocidolite-exposed mice as com-
pared to nonexposed mice. Our study is the
first attempt to quantify and qualify the
mutagenic potential in vivo with respect to a
physiologically based and controlled mode
of exposure (nose-only inhalation) without
overload and with the respect to AM
clearance offibers.
Our study shows that mutagenesis is an
early event in fiber intoxication, which could
be evoked in cell transformation due to
asbestos fibers. In addition, a low dose of
fibers, as compared to previous studies, is
sufficient to observe mutagenesis in situ in
lung DNA. The mice paradigm developed in
this study should now be experienced with
man-made mineral fiber with (e.g., ceramic
fibers) and without (e.g., glass fiber) known
carcinogenic potential in rodents. It would
also be useful to measure the mutant fre-
quency in vivo using asbestos ofvarious sizes
to correlate, if possible, the mutagenic and
the carcinogenic potential offibers in vivo.
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